Karin van den Hurk
- Co-authors
- Véronique WinnepenninckxJoost J. van den OordManon van EngelandMaurice A. M. Van SteenselJürgen VeeckRonald P. MensinkAdriaan DuijvestijnAxel zur Hausen
- Topics
- Melanoma and MAPK Pathways (3 papers)Epigenetics and DNA Methylation (2 papers)Computational Drug Discovery Methods (2 papers)
- Cited by
- Cancer ResearchRheumatologyGenetics
- Partner nations
- NetherlandsBelgiumGermany
In The Last Decade
Karin van den Hurk
10 papers receiving 292 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 170
- Cancer Research 66
- Oncology 55
- Rheumatology 54
- Immunology 52
Countries citing papers authored by Karin van den Hurk
This map shows the geographic impact of Karin van den Hurk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin van den Hurk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin van den Hurk more than expected).
Fields of papers citing papers by Karin van den Hurk
This network shows the impact of papers produced by Karin van den Hurk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin van den Hurk. The network helps show where Karin van den Hurk may publish in the future.
Co-authorship network of co-authors of Karin van den Hurk
This figure shows the co-authorship network connecting the top 25 collaborators of Karin van den Hurk. A scholar is included among the top collaborators of Karin van den Hurk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin van den Hurk. Karin van den Hurk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | [Thrombocytopenia]. | 1 |
| 3 | 57 | |
| 4 | 37 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 61 | |
| 8 | 33 | |
| 9 | 42 | |
| 10 | 44 |
About Karin van den Hurk
Karin van den Hurk is a scholar working on Genetics, Immunology and Allergy and Rheumatology, having authored 10 papers that have together received 297 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Epigenetics and DNA Methylation (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Cancer Research (66 citations), Rheumatology (54 citations) and Genetics (36 citations). Karin van den Hurk has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Véronique Winnepenninckx, Joost J. van den Oord, Manon van Engeland, Maurice A. M. Van Steensel, Jürgen Veeck, Ronald P. Mensink, Adriaan Duijvestijn, Axel zur Hausen, Jogchum Plat and Hanneke E.C. Niessen. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.